Literature DB >> 15229512

Cannabinoids cool the intestine.

George Kunos, Pál Pacher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15229512      PMCID： PMC2516444          DOI： 10.1038/nm0704-678

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  17 in total

1.  Modulation of anxiety through blockade of anandamide hydrolysis.

Authors:  Satish Kathuria; Silvana Gaetani; Darren Fegley; Fernando Valiño; Andrea Duranti; Andrea Tontini; Marco Mor; Giorgio Tarzia; Giovanna La Rana; Antonio Calignano; Arcangela Giustino; Maria Tattoli; Maura Palmery; Vincenzo Cuomo; Daniele Piomelli
Journal:  Nat Med       Date:  2002-12-02       Impact factor: 53.440

Review 2.  Anti-TNF-alpha therapies: the next generation.

Authors:  Michael A Palladino; Frances Rena Bahjat; Emmanuel A Theodorakis; Lyle L Moldawer
Journal:  Nat Rev Drug Discov       Date:  2003-09       Impact factor: 84.694

3.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

4.  Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation.

Authors:  A A Izzo; F Fezza; R Capasso; T Bisogno; L Pinto; T Iuvone; G Esposito; N Mascolo; V Di Marzo; F Capasso
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

5.  Differential roles of CB1 and CB2 cannabinoid receptors in mast cells.

Authors:  Maria-Teresa Samson; Andrea Small-Howard; Lori M N Shimoda; Murielle Koblan-Huberson; Alexander J Stokes; Helen Turner
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

6.  Role of cannabinoid CB1 receptors and tumor necrosis factor-alpha in the gut and systemic anti-inflammatory activity of SR 141716 (rimonabant) in rodents.

Authors:  Tiziano Croci; Marco Landi; Anne-Marie Galzin; Pietro Marini
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

7.  An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice.

Authors:  Angelo A Izzo; Francesco Capasso; Anna Costagliola; Tiziana Bisogno; Giovanni Marsicano; Alessia Ligresti; Isabel Matias; Raffaele Capasso; Luisa Pinto; Francesca Borrelli; Aldo Cecio; Beat Lutz; Nicola Mascolo; Vincenzo Di Marzo
Journal:  Gastroenterology       Date:  2003-09       Impact factor: 22.682

8.  Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor.

Authors:  Jie Liu; Sándor Batkai; Pál Pacher; Judith Harvey-White; Jens A Wagner; Benjamin F Cravatt; Bin Gao; George Kunos
Journal:  J Biol Chem       Date:  2003-08-29       Impact factor: 5.157

9.  Cannabinoids ablate release of TNFalpha in rat microglial cells stimulated with lypopolysaccharide.

Authors:  Fabrizio Facchinetti; Elda Del Giudice; Sara Furegato; Marzla Passarotto; Alberta Leon
Journal:  Glia       Date:  2003-01-15       Impact factor: 7.452

10.  Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview Survey.

Authors:  Teresa Longobardi; Philip Jacobs; Charles N Bernstein
Journal:  Am J Gastroenterol       Date:  2003-05       Impact factor: 10.864
View more
  14 in total

1.  Constitutive activity at the cannabinoid CB(1) receptor and behavioral responses.

Authors:  Katherine E Hanlon; Todd W Vanderah
Journal:  Methods Enzymol       Date:  2010       Impact factor: 1.600

2.  Tolerance to cannabinoid response on the myenteric plexus of guinea-pig ileum and human small intestinal strips.

Authors:  Fabio Guagnini; Paola Cogliati; Sylvain Mukenge; Gianfranco Ferla; Tiziano Croci
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

3.  Cannabis and endocannabinoid modulators: Therapeutic promises and challenges.

Authors:  Igor Grant; B Rael Cahn
Journal:  Clin Neurosci Res       Date:  2005

4.  Profiles of Patients Who Use Marijuana for Inflammatory Bowel Disease.

Authors:  Ann Marie Kerlin; Millie Long; Michael Kappelman; Christopher Martin; Robert S Sandler
Journal:  Dig Dis Sci       Date:  2018-03-29       Impact factor: 3.199

Review 5.  Cannabinoids and cancer: pros and cons of an antitumour strategy.

Authors:  Maurizio Bifulco; Chiara Laezza; Simona Pisanti; Patrizia Gazzerro
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

Review 6.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

7.  Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P.

Authors:  F Guagnini; M Valenti; S Mukenge; I Matias; A Bianchetti; S Di Palo; G Ferla; V Di Marzo; T Croci
Journal:  Gut       Date:  2006-01-19       Impact factor: 23.059

Review 8.  CEACAM1 and the regulation of mucosal inflammation.

Authors:  T Nagaishi; Z Chen; L Chen; H Iijima; A Nakajima; R S Blumberg
Journal:  Mucosal Immunol       Date:  2008-11       Impact factor: 7.313

9.  Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis.

Authors:  Christoph W Michalski; Tamara Laukert; Danguole Sauliunaite; Pál Pacher; Frank Bergmann; Nitin Agarwal; Yun Su; Thomas Giese; Nathalia A Giese; Sándor Bátkai; Helmut Friess; Rohini Kuner
Journal:  Gastroenterology       Date:  2007-02-21       Impact factor: 22.682

Review 10.  Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation.

Authors:  K L Wright; M Duncan; K A Sharkey
Journal:  Br J Pharmacol       Date:  2007-10-01       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.